MIRM Mirum Pharmaceuticals, Inc.

NASDAQ
$83.92

Mirum Pharmaceuticals, Inc. (MIRM) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Moderately bearish Selling ran elevated versus MIRM's own trailing one-year pace, with 64% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
3
18 transactions
Purchases
$0
0 shares
Sales
$13.8M
133,442 shares
Net activity
-$13.8M
purchases less sales

How much of that selling was preplanned? 64% planned / 36% discretionary

10b5-1 plan sales $8.9M 16 transactions · 83,499 shares
Discretionary sales $5.0M 2 transactions · 49,943 shares

Largest single sale: $4.0M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: January 23, 2026 , by Heron Patrick J .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER Sell 9,943 $98.37 $978.1K 44,745 −18.2% of holding
Howe Jolanda SVP, GLOBAL CONTROLLER Sell 10b5-1 658 $100.00 $65.8K 616 −51.6% of holding
Peetz Christopher 2 fills CHIEF EXECUTIVE OFFICER Sell 10b5-1 30,000 $98.68 $3.0M 216,128 −12.2% of holding
Howe Jolanda SVP, GLOBAL CONTROLLER Sell 40,000 $100.00 $4.0M 1,274 −96.9% of holding
BJERKHOLT ERIC CHIEF FINANCIAL OFFICER Sell 10b5-1 6,001 $99.90 $599.5K 36,355 −14.2% of holding
Peetz Christopher 3 fills CHIEF EXECUTIVE OFFICER Sell 10b5-1 20,000 $98.92 $2.0M 202,626 −9% of holding
Howe Jolanda SVP, GLOBAL CONTROLLER Sell 10b5-1 1,840 $105.29 $193.7K 1,274 −59.1% of holding
Peetz Christopher 4 fills CHIEF EXECUTIVE OFFICER Sell 10b5-1 20,000 $122.27 $2.4M 202,175 −9% of holding
BJERKHOLT ERIC 4 fills CHIEF FINANCIAL OFFICER Sell 10b5-1 5,000 $122.25 $611.3K 44,057 −10.2% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.